Related Experiment Video
Updated: Jun 22, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
The suppression of MAD1 by AKT-mediated phosphorylation activates MAD1 target genes transcription
Chao-Kai Chou1, Dung-Fang Lee, Hui-Lung Sun
1Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
MAX dimerization protein 1 (MAD1) is a transcription suppressor that antagonizes MYC-mediated transcription activation, and the inhibition mechanism occurs mainly through the competition of target genes' promoter MYC binding sites by MAD1. The promoter binding proteins switch between MYC and MAD1 affects cell proliferation and differentiation. However, little is known about MAD1's regulation process in cancer cells. Here, we present evidence that AKT inhibits MAD1-mediated transcription repression by physical interaction with and phosphorylation of MAD1. Phosphorylation reduces the binding affinity between MAD1 and its target genes' promoter and thereby abolishes its transcription suppression function. Mutation of the phosphorylation site from serine to alanine rescues the DNA-binding ability in the presence of activated AKT. In addition, AKT inhibits MAD1-mediated target genes (hTERT and ODC) transcription repression and promotes cell cycle and cell growth. However, mutated S145A MAD1 abrogates the inhibition by AKT. Thus, our results suggest that phosphorylation of MAD1 by AKT inhibits MAD1-mediated transcription suppression and subsequently activates the transcription of MAD1 target genes.
Insights
AKT phosphorylation inhibits MAX dimerization protein 1 (MAD1) transcription suppression. This process, crucial in cancer cells, activates target gene transcription, promoting cell growth by altering MYC binding dynamics.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Signaling
Background:
- MAX dimerization protein 1 (MAD1) suppresses transcription by competing with MYC for promoter binding sites, influencing cell proliferation and differentiation.
- The regulation of MAD1, particularly in cancer cells, remains poorly understood.
- MYC and MAD1 dynamics at gene promoters are critical for cellular processes.
Purpose of the Study:
- To investigate the regulatory mechanism of MAD1 in cancer cells.
- To elucidate the role of AKT signaling in modulating MAD1's transcriptional repressive function.
- To understand how AKT-mediated phosphorylation affects MAD1's interaction with target gene promoters.
Main Methods:
- Co-immunoprecipitation to demonstrate physical interaction between AKT and MAD1.
- In vitro kinase assays to confirm AKT-mediated phosphorylation of MAD1.
- Site-directed mutagenesis (S145A) to assess the role of phosphorylation.
- Quantitative PCR and reporter assays to measure target gene transcription (hTERT, ODC).
- Cell cycle analysis and cell proliferation assays.
Main Results:
- AKT physically interacts with and phosphorylates MAD1.
- Phosphorylation of MAD1 by AKT reduces its DNA-binding affinity, abolishing transcription repression.
- Mutation of the phosphorylation site (S145A) abrogates AKT-mediated inhibition.
- AKT promotes cell cycle progression and growth by inhibiting MAD1-mediated repression of target genes like hTERT and ODC.
Conclusions:
- AKT-mediated phosphorylation of MAD1 is a key regulatory mechanism that inhibits its transcriptional suppressor activity.
- This phosphorylation event releases the repression of MAD1 target genes, thereby promoting cell cycle progression and growth in cancer cells.
- Targeting the AKT-MAD1 interaction could offer a novel therapeutic strategy in cancers where this pathway is dysregulated.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Abnormal Proliferation

